Winton Group LTD Baxter International Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $662,108 - $789,628	16,561 New	16,561 $754,000
Q1 2022 May 11, 2022	SELL	$76.85 - $89.45 $1.03 Million - $1.19 Million	-13,346 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$74.57 - $87.19 $725,715 - $848,533	-9,732 Reduced 42.17%	13,346 $1.15 Million
Q3 2021 Oct 28, 2021	SELL	$73.77 - $83.61 $210,096 - $238,121	-2,848 Reduced 10.99%	23,078 $1.86 Million
Q2 2021 Aug 10, 2021	BUY	$80.5 - $88.01 $2.09 Million - $2.28 Million	25,926 New	25,926 $2.09 Million
Q4 2019 Feb 13, 2020	SELL	$76.7 - $88.45 $2.23 Million - $2.58 Million	-29,130 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$81.4 - $89.78 $342,042 - $377,255	4,202 Added 16.86%	29,130 $2.55 Million
Q2 2019 Jul 08, 2019	BUY	$73.44 - $82.41 $1.36 Million - $1.53 Million	18,585 Added 293.0%	24,928 $2.04 Million
Q1 2019 May 13, 2019	SELL	$64.48 - $81.31 $137,858 - $173,840	-2,138 Reduced 25.21%	6,343 $516,000
Q4 2018 Feb 05, 2019	BUY	$61.45 - $77.8 $358,192 - $453,496	5,829 Added 219.8%	8,481 $558,000
Q3 2018 Nov 02, 2018	SELL	$70.71 - $77.75 $889,602 - $978,172	-12,581 Reduced 82.59%	2,652 $0
Q2 2018 Aug 20, 2018	BUY	$63.43 - $75.41 $468,367 - $556,827	7,384 Added 94.08%	15,233 $0
Q1 2018 May 21, 2018	SELL	$62.56 - $72.26 $54,614 - $63,082	-873 Reduced 10.01%	7,849 $0
Q4 2017 Feb 13, 2018	SELL	$61.45 - $66.05 $2.6 Million - $2.79 Million	-42,254 Reduced 82.89%	8,722 $564,000
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $294,822 - $320,142	4,955 Added 10.77%	50,976 $3.2 Million
Q2 2017 Aug 17, 2017	BUY	N/A	46,021	46,021 $2.79 Million

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account